Valion Bio announces the sale of preferred shares and options totaling $4.77 million.
Valion Bio announces the sale of preferred shares and options totaling $4.77 million.
Want to see every report in real time?
Hundreds of sources worldwide, translated into your language, with alerts for what matters to you.
Sign up free Already have an account? Log in